sepol capsules
aversi-rational ltd - fluconazole - capsules - 150mg
nordimet
nordic group b.v. - methotrexate - arthritis, psoriatic, psoriasis, arthritis, juvenile rheumatoid, arthritis, rheumatoid - antineoplastic agents, - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet a (puva), and retinoids, and severe psoriatic arthritis in adult patients.
sylvet capsules
arthropharm pty ltd - calcium pentosan polysulfate - oral capsule - calcium pentosan polysulfate mineral-calcium active 488.88 g/kg - musculoskeletal system - dog | bitch | castrate | puppy - osteoarthritis
cvs single use lubricant eye drops- polyethylene glycol 400, and propylene glycol solution/ drops
bershtel enterprises llc - propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3), polyethylene glycol 400 (unii: b697894sgq) (polyethylene glycol 400 - unii:b697894sgq) - propylene glycol 3 mg - usefor the temporary relief of burning and irritation due to dryness of the eye stop use and ask a doctor ifyou feel eye painchanges in vision occurredness or irritation of the eye(s) get worse, persists or lasts more than 72 hours directions instill 1 or 2 drops in the affected eye(s) as needed.
septrin paediatric suspension
aspen bad oldesloe gmbh - trimethoprim, sulfamethoxazole - suspension - 8mg/ml+40mg/ml
yarina plus 3mg+30mcg+451mcg tablets film-coated
bayer weimar gmbh & co. kg - drospirenone, ethinylestradiol, levomefolate calcium - tablets film-coated - 3mg+30mcg+451mcg
zeposia- ozanimod hydrochloride capsule zeposia 7-day starter pack- ozanimod hydrochloride kit zeposia starter kit- ozanimod h
celgene corporation - ozanimod hydrochloride (unii: 3upr33jaam) (ozanimod - unii:z80293urpv) - zeposia is indicated for the treatment of: zeposia is contraindicated in patients who: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to zeposia during pregnancy. healthcare providers are encouraged to register patients on-line, or pregnant women may register themselves at https://www.zeposiapregnancyregistry.com/or by calling 1-877-301-9314. currently this registry is enrolling women with ms. information regarding registration of pregnant women with uc will be made available in the future. risk summary there are no adequate data on the developmental risk associated with the use of zeposia in pregnant women. in animal studies, administration of ozanimod during pregnancy produced adverse effects on development, including embryolethality, an increase in fetal malformations, and neurobehavioral changes, in the absence of maternal toxicity. in rabbits, fetal blood vessel malformations occurred at clinically relevant maternal ozanimod and metab
zeposia 0.23 mg
bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - capsules - ozanimod as hydrochloride 0.23 mg - ozanimod - zeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features.zeposia is indicated for the treatment of moderately to severely active ulcerative colitis (uc) in adults.
zeposia 0.46 mg
bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - capsules - ozanimod as hydrochloride 0.46 mg - ozanimod - zeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features.zeposia is indicated for the treatment of moderately to severely active ulcerative colitis (uc) in adults.
zeposia 0.92 mg
bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - capsules - ozanimod as hydrochloride 0.92 mg - ozanimod - zeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features.zeposia is indicated for the treatment of moderately to severely active ulcerative colitis (uc) in adults.